CITADEL ADVISORS LLC 13D/13G Filings for Millendo Therapeutics, Inc. (MLND)

CITADEL ADVISORS LLC 13D and 13G filings for Millendo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-03-15
7:54 pm
Purchase
2021-03-03 13G Millendo Therapeutics, Inc.
MLND
CITADEL ADVISORS LLC 61,777
4.900%
61,777increase
(New Position)
Filing